A similar approach was used in models of non-small cell lung cancer, using 5′-3p-siRNA sequences against vascular endothelial growth factor (VEGF), resulting in reduced tumor angiogenesis while enhancing anti-tumor immunity [91]. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.